English

SmartCella represents business sector in Swedish Government delegation to Boston

SmartCella and Catalent sign nonexclusive license agreement for GMP iPSCs

SmartCella appoints Professor Jan Lundberg to Scientific Advisory Board

First patient dosed in XyloCor Therapeutics’ Phase IIb trial using SmartCella’s Extroducer delivery platform

SmartCella forms Scientific Advisory Board with leading global scientific experts

Procella obtains regulatory approval to widen the scope of cell therapy manufacturing for clinical stages

SmartCella publishes its 2024 Annual Report

SmartCella enters agreement to advance Professor Johan Ericson’s research on cell replacement therapies for Parkinson’s disease

SmartCella granted new European patent for the Extroducer delivery platform

XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart